- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Uterine Contraction.
Displaying page 1 of 1.
EudraCT Number: 2009-012323-29 | Sponsor Protocol Number: FE200440CS11 | Start Date*: 2009-12-22 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, double-blind, parallel groups, placebo-controlled, multi-centre trial in oocyte donors assessing the effects of barusiban, a selective oxytocin antagonist, on uterine contractions on ... | |||||||||||||
Medical condition: Co-adjuvant therapy in the luteal phase to prevent embryo expulsion and facilitate implantation and pregnancy in women undergoing assisted reproductive technologies (i.e. IVF/ICSI with embryo trans... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003158-27 | Sponsor Protocol Number: FE 200440 CS09 | Start Date*: 2007-09-20 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, double-blind, parallel groups, placebo-controlled, multi-centre study assessing the effects of a selective oxytocin antagonist (barusiban) and a mixed oxytocin antagonist – vasopressi... | |||||||||||||
Medical condition: Co-adjuvant therapy in the luteal phase to facilitate implantation and pregnancy in women undergoing assisted reproductive technologies (i.e. IVF/ICSI with embryo transfer) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) PL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003412-20 | Sponsor Protocol Number: DV-MV-MO | Start Date*: 2016-08-01 |
Sponsor Name:Basque Health System | ||
Full Title: Efficacy and safety of hourly titrated misoprostol versus vaginal dinoprostone and misoprostol for cervical ripening and labor induction: randomized clinical trial. | ||
Medical condition: labor induction | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000026-30 | Sponsor Protocol Number: ABR35278 | Start Date*: 2013-05-08 | |||||||||||
Sponsor Name:Academic medical centre | |||||||||||||
Full Title: Induction of Labour with a Foley catheter or oral Misoprostol at Term | |||||||||||||
Medical condition: Induction of labour at term | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002374-12 | Sponsor Protocol Number: v2_29.05.2016 | Start Date*: 2016-12-23 | |||||||||||
Sponsor Name:Helsinki University Central Hospital/ Women's hospital | |||||||||||||
Full Title: Oxycodone compared to meperidine in the treatment of labour pain | |||||||||||||
Medical condition: Labour pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004726-42 | Sponsor Protocol Number: 17/BW/MAT/PO14 | Start Date*: 2017-02-15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Birmingham Women's Hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Randomised controlled trial on the use of synthetic osmotic cervical dilator in induction of labour in comparison to dinoprostone vaginal insert | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Induction of Labour | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002640-23 | Sponsor Protocol Number: APHP200003 | Start Date*: 2020-12-14 |
Sponsor Name:ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS | ||
Full Title: Effect of increased oxytocin doses on the mode of delivery in obese primiparous women with spontaneous labour. A double-blind, randomised, controlled trial | ||
Medical condition: To compare the rates of caesarean section in obese patients with spontaneous labour between two oxytocin dosage regimens | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005021-21 | Sponsor Protocol Number: PIPIN | Start Date*: 2018-03-26 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: A feasibility study investigating pravastatin for the prevention of preterm birth in women | |||||||||||||
Medical condition: Preterm Birth | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000145-40 | Sponsor Protocol Number: versión2.febrero2017 | Start Date*: 2017-09-20 |
Sponsor Name:montserrat zamora brito | ||
Full Title: Use of acupuncture for the reduction of hospital admissions in the induction of labor due to chronologically prolonged gestation. ACUPUNT STUDY | ||
Medical condition: This Clinical Trial will evaluate the efficacy and safety of acupuncture to promote labor in pregnant women who need an induction at birth and thus be able to give answers to all these women who a... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002561-19 | Sponsor Protocol Number: 1 | Start Date*: 2014-03-06 | ||||||||||||||||
Sponsor Name:Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Geburtshilfe und Feto-maternale Medizin | ||||||||||||||||||
Full Title: A prospective, double blind, randomised, placebo controlled trial to evaluate the effect of a long term tokolysis with atosiban on the pregnancy outcome. A pilot study. | ||||||||||||||||||
Medical condition: Premature uterine contractions premature labor | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005683-41 | Sponsor Protocol Number: RIOTB2015 | Start Date*: 2016-03-16 | |||||||||||||||||||||
Sponsor Name:Sven O. Skouby, Professor, MD, DMSc. Unit of reproductive Medicine, Herlev/Gentofte Hospital | |||||||||||||||||||||||
Full Title: REDUCING THE IMPACT OF OVARIAN STIMULATION - THE RIOT PROJECT RIOT STUDY B: MAPPING THE ENDOCRINE DETERMINANTS OF OVARIAN STIMULATION TO OPTIMIZE OUTCOMES IN FRESH EMBRYO TRANSFER CYCLES ... | |||||||||||||||||||||||
Medical condition: Infertility | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005682-24 | Sponsor Protocol Number: RIOTA2015 | Start Date*: 2016-03-16 | |||||||||||||||||||||
Sponsor Name:Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital | |||||||||||||||||||||||
Full Title: REDUCING THE IMPACT OF OVARIAN STIMULATION - THE RIOT PROJECT STUDY RIOT A: THE ROLE OF AROMATASE INHIBITOR IN REDUCING THE DETRIMENTAL EFFECTS OF OVARIAN STIMULATION TO OPTIMIZE OUTCOMES IN FRESH... | |||||||||||||||||||||||
Medical condition: Infertility | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000843-57 | Sponsor Protocol Number: CRO22001 | Start Date*: 2022-11-02 |
Sponsor Name:RONTIS HELLAS S.A. | ||
Full Title: A double-blind, randomized, cross-over, multi-center efficacy and safety study of ibuprofen plus hyoscine butylbromide for pain management due to primary dysmenorrhea | ||
Medical condition: The efficacy and safety of ibuprofen plus hyoscine butylbromide for pain management due to primary dysmenorrhea will be investigated. Primary dysmenorrhea is the most common gynecological complaint... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BG (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.